Therefore, it has emerged as a potential candidate for the treatment of various autoimmune and inflammatory diseases; VIP has also been shown to be effective in the prevention of autoimmune diseases, such as diabetes mellitus, rheumatoid arthritis, EAE, sepsis and inflammatory bowel disease [11, 23–27]. This evidence concerns the gene VIP and diabetes mellitus.